CLINICAL_TRIALS
research
· 2025-02-18
Clinical Trial Update: Esketamine for the Treatment of Rett Syndrome [EARLY_Phase 1]
Summary
An early-phase (Phase 1) trial is evaluating esketamine for Rett syndrome, sponsored by the Children's Hospital of Fudan University; the study is currently acti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital of Fudan University | Conditions: Rett Syndrome | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING